array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(28) "Bristol-Myers Squibb Company"
["slug"]=>
string(37) "81631-us-bristol-myers-squibb-company"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13"
["description"]=>
string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome.
Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients.
Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do.
Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html"
["address_street"]=>
string(19) "430 E 29TH St FL 14"
["address_place"]=>
string(8) "New York"
["address_region"]=>
string(8) "New York"
["founding_date"]=>
string(10) "1887-02-28"
["website_domain"]=>
string(7) "bms.com"
["website_url"]=>
string(19) "https://www.bms.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(1200)
["article_count"]=>
int(2511)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(91) "Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS | BioSpace"
["snippet_en"]=>
string(206) "Seeking a potential slice of the challenging KRAS market, Merck has launched a Phase III trial of its oral G12C inhibitor MK-1084, in combination with Keytruda, in pursuit of Amgen and Bristol Myers Squibb."
["url"]=>
string(113) "https://www.biospace.com/article/merck-launches-phase-iii-study-for-kras-hopeful-eyes-challenge-to-amgen-and-bms/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4b937899-1b0f-42a9-a60d-25584b0ef4ce"
["source"]=>
string(12) "biospace.com"
["publication_date"]=>
string(10) "2024-04-05"
["categories"]=>
array(3) {
[0]=>
string(10) "New Market"
[1]=>
string(11) "Competition"
[2]=>
string(14) "Product Launch"
}
}
[1]=>
array(7) {
["title_en"]=>
string(66) "Med Reps: cuts for Bayer, BMS and GSK and other news in the market"
["snippet_en"]=>
string(105) "Layoffs, corporate mergers and new FDA approvals are impacting the work of Med Reps. Discover what's new."
["url"]=>
string(86) "https://informatori.it/flash-news/aziende/med-reps-tagli-bayer-bms-gsk-novita-mercato/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/aa700b35-9efe-48a9-afd2-20d9e09df9d8"
["source"]=>
string(14) "informatori.it"
["publication_date"]=>
string(10) "2024-04-02"
["categories"]=>
array(3) {
[0]=>
string(11) "Competition"
[1]=>
string(15) "Market Movement"
[2]=>
string(7) "Layoffs"
}
}
[2]=>
array(7) {
["title_en"]=>
string(153) "Pancreatic Cancer Therapeutics and Diagnostics Market 2024 Trends | Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company - Amoré"
["snippet_en"]=>
string(153) "Pancreatic Cancer Therapeutics and Diagnostics Market 2024 Trends | Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company - Amoré"
["url"]=>
string(168) "https://amore.ng/worldwide/22/pancreatic-cancer-therapeutics-and-diagnostics-market-2024-trends-myriad-genetics-inc-pfizer-inc-novartis-ag-bristol-myers-squibb-company/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b1f9c0ea-a7dc-4a94-a87f-9f2aec97c24e"
["source"]=>
string(8) "amore.ng"
["publication_date"]=>
string(10) "2024-03-19"
["categories"]=>
array(1) {
[0]=>
string(11) "Competition"
}
}
[3]=>
array(7) {
["title_en"]=>
string(116) "Non-Hematological Cancers Market to See Incredible Growth 2024-2031 |Novartis, Pfizer, Bristol-Myers Squibb - Amoré"
["snippet_en"]=>
string(116) "Non-Hematological Cancers Market to See Incredible Growth 2024-2031 |Novartis, Pfizer, Bristol-Myers Squibb - Amoré"
["url"]=>
string(135) "https://amore.ng/worldwide/14/non-hematological-cancers-market-to-see-incredible-growth-2024-2031-novartis-pfizer-bristol-myers-squibb/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c717e747-4d2e-4473-9ce2-31a6ecf71096"
["source"]=>
string(8) "amore.ng"
["publication_date"]=>
string(10) "2024-03-13"
["categories"]=>
array(2) {
[0]=>
string(11) "Competition"
[1]=>
string(15) "Market Movement"
}
}
[4]=>
array(7) {
["title_en"]=>
string(82) "J&J develops edible psoriasis drug...Competing with BMS ‘Sotictu’ - Comedy.com"
["snippet_en"]=>
string(317) "Global healthcare company Johnson & Johnson (J&J) has succeeded in late-stage clinical trials for an oral plaque psoriasis treatment. It is expected to create a direct competition with BMS ‘Sotictu (ingredient name: ducravasitinib)’, which emerged as the first targeted oral treatment option in the disease field."
["url"]=>
string(157) "https://kormedi.com/1671227/jj-%eb%a8%b9%eb%8a%94-%ea%b1%b4%ec%84%a0%ec%95%bd-%ea%b0%9c%eb%b0%9c-bms-%ec%86%8c%ed%8b%b1%ed%88%ac%ec%99%80-%ea%b2%bd%ec%9f%81/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e1938575-d0f7-42f2-93f2-213358247b88"
["source"]=>
string(11) "kormedi.com"
["publication_date"]=>
string(10) "2024-03-12"
["categories"]=>
array(1) {
[0]=>
string(11) "Competition"
}
}
[5]=>
array(7) {
["title_en"]=>
string(94) "Sex Toys Market to Expand Robustly in 2024| Ansell, BMS Factory, LELO, LUVU BRANDS - Newstrail"
["snippet_en"]=>
string(155) "Advance Market Analytics published a new research publication on "Sex Toys Market Insights, to 2030" with 232 pages and enriched with self-explained Tables"
["url"]=>
string(105) "https://www.newstrail.com/sex-toys-market-to-expand-robustly-in-2024-ansell-bms-factory-lelo-luvu-brands/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/2e9956f5-5f48-4a99-b9fc-73a8f01c6ae6"
["source"]=>
string(13) "newstrail.com"
["publication_date"]=>
string(10) "2024-03-08"
["categories"]=>
array(3) {
[0]=>
string(11) "Competition"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(15) "Market Movement"
}
}
[6]=>
array(7) {
["title_en"]=>
string(111) "Edo-based Missionary School Emerges Second Best In World Mathematics Tournament | Independent Newspaper Nigeria"
["snippet_en"]=>
string(297) "Edo-based Baptist Mission School (BMS), has emerged the second best secondary school in the 2024 World Mathematics Tournament (WMT). The fourth edition of the competition organised virtually by the Mathematics for Life Foundation for Secondary/High school students globally, saw students from BMS,"
["url"]=>
string(103) "https://independent.ng/edo-based-missionary-school-emerges-second-best-in-world-mathematics-tournament/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5959aa82-2040-4b90-8a43-1716f389ed11"
["source"]=>
string(14) "independent.ng"
["publication_date"]=>
string(10) "2024-03-04"
["categories"]=>
array(2) {
[0]=>
string(17) "Academic Research"
[1]=>
string(11) "Competition"
}
}
[7]=>
array(7) {
["title_en"]=>
string(66) "BMS to build fifth cell therapy plant in response to CAR-T success"
["snippet_en"]=>
string(130) "After recent CAR-T cell therapy success, BMS will build its fifth advanced therapy manufacturing plant in Leiden, The Netherlands."
["url"]=>
string(116) "https://www.bioprocessintl.com/bioprocess-insider/bms-to-build-fifth-cell-therapy-plant-in-response-to-car-t-success"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9c5e3bb1-81e5-445f-b958-e7f8ad95e0b5"
["source"]=>
string(18) "bioprocessintl.com"
["publication_date"]=>
string(10) "2024-02-07"
["categories"]=>
array(2) {
[0]=>
string(11) "Competition"
[1]=>
string(18) "Expansion & Growth"
}
}
[8]=>
array(7) {
["title_en"]=>
string(186) "Recombinant Therapeutic Protein Market To Witness the Highest Growth Globally in Coming Years 2023-2030 | Boehringer Ingelheim, Regeneron Pharmaceuticals, Eli Liily, Bristol-Myers Squibb"
["snippet_en"]=>
string(96) "The global Recombinant Therapeutic Protein Market has witnessed significant recent developments,"
["url"]=>
string(233) "https://www.digitaljournal.com/pr/news/cdn-newswire/recombinant-therapeutic-protein-market-to-witness-the-highest-growth-globally-in-coming-years-2023-2030-boehringer-ingelheim-regeneron-pharmaceuticals-eli-liily-bristol-myers-squibb"
["image_url"]=>
NULL
["source"]=>
string(18) "digitaljournal.com"
["publication_date"]=>
string(10) "2023-10-05"
["categories"]=>
array(3) {
[0]=>
string(11) "Competition"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(15) "Market Movement"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(252)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(165)
}
[2]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(153)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(94)
}
[4]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(87)
}
[5]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(77)
}
[6]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(75)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(64)
}
[8]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(63)
}
[9]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(60)
}
[10]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(60)
}
[11]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(57)
}
[12]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(55)
}
[13]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(47)
}
[14]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(47)
}
[15]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(46)
}
[16]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(45)
}
[17]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(42)
}
[18]=>
array(2) {
["name"]=>
string(8) "Verdicts"
["count"]=>
int(41)
}
[19]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(36)
}
[20]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(35)
}
[21]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(35)
}
[22]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(33)
}
[23]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(28)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(27)
}
[25]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(26)
}
[26]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(24)
}
[27]=>
array(2) {
["name"]=>
string(6) "Energy"
["count"]=>
int(22)
}
[28]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(22)
}
[29]=>
array(2) {
["name"]=>
string(9) "Valuation"
["count"]=>
int(21)
}
}
}
81631-us-bristol-myers-squibb-company
Bristol-Myers Squibb Company
Location
New York
Founded
1887-02-28
Website
https://www.bms.com
Articles
2511 Articles
Category
Pharmaceutical Preparations
Description
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome.
Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients.
Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do.
Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
Seeking a potential slice of the challenging KRAS market, Merck has launched a Phase III trial of its oral G12C inhibitor MK-1084, in combination with Keytruda, in pursuit of Amgen and Bristol Myers Squibb.
Global healthcare company Johnson & Johnson (J&J) has succeeded in late-stage clinical trials for an oral plaque psoriasis treatment. It is expected to create a direct competition with BMS ‘Sotictu (ingredient name: ducravasitinib)’, which emerged as the first targeted oral treatment option in the disease field.
Advance Market Analytics published a new research publication on "Sex Toys Market Insights, to 2030" with 232 pages and enriched with self-explained Tables
Edo-based Baptist Mission School (BMS), has emerged the second best secondary school in the 2024 World Mathematics Tournament (WMT). The fourth edition of the competition organised virtually by the Mathematics for Life Foundation for Secondary/High school students globally, saw students from BMS,
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
